Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Starkeya sp. ORNL1

ABSTRACT: Starkeya rhizosphaerae ORNL1 Genome sequencing and assembly

PROVIDER: PRJNA606081 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR11248247_subreads.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Starkeya sp. OAE587

Project description:Starkeya sp. OAE587 Genome sequencing

| PRJNA712271 | ENA

Starkeya sp. OAE902

Project description:Starkeya sp. OAE902 Genome sequencing

| PRJNA580618 | ENA

Starkeya

Project description:Starkeya sp. overview

| PRJNA606838 | ENA

WGS Starkeya veronica

Project description:Whole-genome sequencing of Starkeya veronica

| PRJEB35169 | ENA

Micractinium sp. NFX-FRZ

Project description:Micractinium rhizosphaerae NFX-FRZ Genome sequencing

| PRJNA901669 | ENA

Lysinibacillus sp. SC-N022

Project description:Lysinibacillus rhizosphaerae SC-N022 genome sequencing

| PRJNA346228 | ENA

Complete Genome Sequence of Starkeya sp. Strain ORNL1, a Soil Alphaproteobacterium Isolated from the Rhizosphere of Populus deltoides.

Project description:Starkeya sp. strain ORNL1 is an alphaproteobacterium isolated from the rhizosphere of an Eastern cottonwood tree. Starkeya spp. are physiologically versatile, using a wide range of nutritional and energetic resources and serving important ecological roles in carbon and sulfur cycling. The 6.3-Mb chromosome of Starkeya sp. strain ORNL1 was completely sequenced and will help in understanding nutrient cycles.

| S-EPMC7330251 | biostudies-literature

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Brucella rhizosphaerae SJY1

Project description:Brucella rhizosphaerae SJY1 Genome sequencing and assembly

| PRJNA231972 | ENA

Ancylobacter novellus DSM 506

Project description:Starkeya novella DSM 506 genome sequencing project

| PRJNA37659 | ENA